Author Affiliations
11. State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Chemistry and Chemical Engineering, Hunan University, Changsha 410082, China22. Hunan Key Lab of Biomedical Materials and Devices, College of Life Sciences and Chemistry, Hunan University of Technology, Zhuzhou 412008, China33. National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, State Key Laboratory Breeding Base of Dao-di Herbs, Beijing 100700, China44. The Modernization Engineering Technology Research Center of Ethnic Minority Medicine of Hubei Province, School of Pharmaceutical Sciences, South-Central University for Nationalities, Wuhan 430074, China55. Beijing Tongrentang Pingjiang Atractylodes Macrocephala Koidz. Co., Ltd., Pingjiang 414500, Chinashow less
Fig. 1. Sampling points of AM in this work
Fig. 2. (a) The relationship between fluorescence intensity of excitation/emission wavelength of 280/355 nm and extractant type and extractant ratio; (b) The relationship between fluorescence intensity of excitation/emission wavelength of 355/430 nm and extractant type and extractant ratio; (c) Variation of fluorescence intensity with ultrasonic time
Fig. 3. Rayleigh scattering eliminated from EEM data by interpolation
(a): Raw data with visible Rayleigh scattering; (b): Defect data after deducting Rayleigh scattering; (c): Data repaired by interpolation
Fig. 4. Typical EEM contour map of AM samples in different provinces after deducting scattering
(a): Anhui AM; (b): Hunan AM; (c): Zhejiang AM
Fig. 5. The normalized excitation spectra profiles (a), the normalized emission spectra profiles (b) and the relative concentration spectra profiles (c) obtained by ATLD analysis of three-way matrix with N=3
Fig. 6. The normalized excitation spectra profiles (a) and normalized emission spectra profiles (b) of 7 standard substances with fluorescence signals that may be contained in AM
Fig. 7. Three-way scatter diagram of training samples based on the scores of the first three latent variables of PLS-DA
| | 样本数 | 东经 | 北纬 | 海拔/m | 温度/℃ | 湿度/% | 天气 |
---|
| 亳州1 | 15 | 115°37'39″—115°37'41″ | 33°44'7″—33°44'10″ | 15.59~26.61 | 11.5~16.4 | 37~43 | 阴 | 安徽省 | 亳州2 | 15 | 115°40'54″ | 33°45'41″—33°44'43″ | 16.09~24.29 | 13.1~16.3 | 30~47 | 阴 | | 亳州3 | 15 | 115°41'0″—115°41'3″ | 33°45'34″—33°44'35″ | 7.84~36.02 | 13.1~16.5 | 38~46 | 阴 | | 平江1 | 15 | 113°35'38″—113°48'4″ | 28°39'13″—28°59'28″ | 75.5~463.3 | 10.2~11.2 | 68~76 | 阴 | 湖南省 | 平江2 | 15 | 114°2'17″—114°2'21″ | 28°47'26″—28°47'32″ | 149.32~158.59 | 13.2~15.3 | 56~59 | 阴 | | 平江3 | 15 | 114°2'16″—114°2'18″ | 28°47'25″—28°47'28″ | 150.00~168.32 | 11.6~12.7 | 65~72 | 阴 | | 磐安 | 10 | 120°23'26″—120°23'28″ | 28°56'46″—28°56'47″ | 60.08~411.71 | 8.3~10.2 | 70~91 | 阴 | 浙江省 | 天台 | 10 | 120°49'2″ | 29°12'5″ | 512.7 | 9.8~13.5 | 56~69 | 阴 | | 新昌 | 15 | 120°49'11″—120°49'13″ | 29°15'8″—29°15'26″ | 433.3~446.92 | 12.5~19 | 49~78 | 阴 |
|
Table 1. Geographical and weather conditions and the number of samples when picking AM (The prediction set samplesare not included)
序号 | 名称 | 分子量 | 浓度/ (μg·mL-1) | 结构式 | 纯度 | 公司 |
---|
1 | 紫丁香苷(Syringin) | 372.4 | 0.17 | | ≥98% | 博美生物科技有限公司 | 2 | β-谷甾醇(β-sitosterol) | 414.7 | 9.7 | | ≥98% | 博美生物科技有限公司 | 3 | 东莨菪内酯(Scopoletin) | 192.2 | 9.68 | | ≥98% | 博美生物科技有限公司 | 4 | 羽扇豆醇(Lupeol) | 426.7 | 8.7 | | ≥98% | 博美生物科技有限公司 | 5 | 芹菜素(Apigenin) | 270.2 | 12.52 | | ≥98% | 博美生物科技有限公司 | 6 | 木香烃内酯(Costunlide) | 232.3 | 12.34 | | 98% | 博美生物科技有限公司 | 7 | 7-羟基香豆素(7-Hydroxycoumarin) | 162.1 | 0.176 | | ≥98% | 博美生物科技有限公司 | 8 | 咖啡酸(Caffeic acid) | 180.2 | 8.68 | | ≥98% | 博美生物科技有线公司 | 9 | 阿魏酸(Ferulic acid) | 194.2 | 9.82 | | ≥98% | 博美生物科技有限公司 | 10 | 原儿茶酸(Protocatechuic acid) | 154.1 | 9.04 | | ≥98% | 博美生物科技有限公司 | 11 | 白术内酯Ⅰ(Atractylenolide Ⅰ) | 230.3 | 9.5 | | ≥98% | 上海源叶生物科技有限公司 | 12 | 白术内酯Ⅱ(Atractylenolide Ⅱ) | 232.3 | 10.08 | | ≥98% | 上海源叶生物科技有限公司 | 13 | 白术内酯Ⅲ(Atractylenolide Ⅲ) | 248.3 | 8.46 | | ≥98% | 上海源叶生物科技有限公司 | 14 | 木犀草素(Luteolin) | 286.2 | 8.4 | | ≥98% | 上海源叶生物科技有限公司 | 15 | 苍术酮(Atractylon) | 216.3 | 8.42 | | ≥98% | 上海源叶生物科技有限公司 | 16 | 苍术素(Atractylodin) | 182.2 | 7.6 | | 99.5% | 成都普思生物科技股份有限公司 | 17 | 苍术苷A(Atractyloside A) | 448.5 | 4.68 | | ≥98% | 甄准生物科技公司 |
|
Table 2. Chinese and English names, molecular weights, concentrations, structural formulas, purity and production companies of 17 standard substances that may exist in AM
模型 | LVs/k | CCR/% | 特异性a/% | 灵敏度b/% |
---|
安徽 | 湖南 | 浙江 | 安徽 | 湖南 | 浙江 |
---|
| | 交叉验证 | 91 | 98 | 92 | 96 | 97 | 91 | 81 | PLS-DA | 10 | 训练集 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | | | 测试集 | 87 | 95 | 89 | 95 | 100 | 91 | 63 | | | 交叉验证 | 88 | 95 | 93 | 94 | 91 | 88 | 85 | kNN | 2 | 训练集 | 88 | 95 | 93 | 94 | 91 | 88 | 85 | | | 测试集 | 73 | 89 | 89 | 82 | 100 | 55 | 63 |
|
Table 3. The complexity parameters (LVs/k) of the PLS-DA and kNN classification models, the classificationaccurate rate, specificity and sensitivity obtained by cross-validation, training set, test set and prediction set
模型 | 真实 |
---|
PLS-DA | kNN |
---|
预测 | 安徽 | 湖南 | 浙江 | 安徽 | 湖南 | 浙江 | | 安徽 | 34 | 0 | 0 | 31 | 1 | 2 | 训练集 | 湖南 | 0 | 34 | 0 | 2 | 30 | 2 | | 浙江 | 0 | 0 | 27 | 1 | 3 | 23 | | 安徽 | 11 | 0 | 1 | 11 | 1 | 1 | 测试集 | 湖南 | 0 | 10 | 2 | 0 | 6 | 2 | | 浙江 | 0 | 1 | 5 | 0 | 4 | 5 | | 安徽 | 0 | 0 | 1 | 0 | 0 | 0 | 预测集 | 湖南 | 0 | 0 | 1 | 0 | 0 | 1 | | 浙江 | 0 | 0 | 8 | 0 | 0 | 9 |
|
Table 4. Confusion matrix of training set, test set and prediction set obtained by PLS-DA and kNN classification methods in AM classification model